We are live on ! Find out more
SBBP

Strongbridge Biopharma plc.
SBBP

Delisted

SBBP was delisted on the 5th of October, 2021.

Back to rankings

64 hedge funds and large institutions have $187M invested in Strongbridge Biopharma plc. in 2018 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 12

4% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 25

2% less funds holding

Funds holding: 65 → 64 (-1)

31% less capital invested

Capital invested by funds: $273M → $187M (-$85.6M)

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
64
Holders Change
-1
Holders Change %
-1.54%
% of All Funds
1.46%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
24
Increased
19
Reduced
12
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LSC
Lyon Street Capital
California
+$10.1M
2
SFM
Sphera Funds Management
Israel
+$4.93M
3
Millennium Management
Millennium Management
New York
+$3.84M
4
Goldman Sachs
Goldman Sachs
New York
+$2.62M
5
PWAM
Park West Asset Management
California
+$2.19M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$9.32M
2
AC
Armistice Capital
New York
-$8.88M
3
BC
Broadfin Capital
New York
-$3.32M
4
State Street
State Street
Massachusetts
-$2.61M
5
Northern Trust
Northern Trust
Illinois
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
26
Paloma Partners
Connecticut
$817K +$996K +136,199 New
Deutsche Bank
27
Deutsche Bank
Germany
$768K +$465K +63,567 +99%
Two Sigma Investments
28
Two Sigma Investments
New York
$647K +$682K +93,175 +634%
LP
29
LMR Partners
United Kingdom
$555K +$677K +92,540 New
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$498K +$607K +82,924 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$435K +$530K +72,431 New
AA
32
ALPS Advisors
Colorado
$396K +$483K +66,083 New
OAM
33
Oxford Asset Management
United Kingdom
$355K +$438K +59,829 New
Squarepoint
34
Squarepoint
New York
$339K +$413K +56,485 New
Barclays
35
Barclays
United Kingdom
$335K +$254K +34,662 +164%
GIP
36
Granite Investment Partners
California
$315K +$206K +28,140 +116%
MWNA
37
Marshall Wace North America
New York
$315K +$384K +52,546 New
Wells Fargo
38
Wells Fargo
California
$253K -$594K -81,127 -66%
PCM
39
Prelude Capital Management
New York
$252K – – –
Geode Capital Management
40
Geode Capital Management
Massachusetts
$225K -$460K -62,897 -63%
GCP
41
GSA Capital Partners
United Kingdom
$204K +$249K +34,000 New
PP
42
PDT Partners
New York
$197K +$240K +32,868 New
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$185K +$225K +30,770 New
Citigroup
44
Citigroup
New York
$183K +$196K +26,809 +726%
SIM
45
Spark Investment Management
New York
$173K +$12.4K +1,700 +6%
Jane Street
46
Jane Street
New York
$154K +$188K +25,684 New
CSS
47
Cubist Systematic Strategies
Connecticut
$130K +$158K +21,587 New
PAM
48
Panagora Asset Management
Massachusetts
$126K -$829K -113,256 -84%
ProShare Advisors
49
ProShare Advisors
Maryland
$115K -$39K -5,325 -22%
DTL
50
Dynamic Technology Lab
Singapore
$110K +$134K +18,375 New
1
2
3 4

SBBP Hedge Fund Activity: Q2 2018 in Review

64 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q2 2018, worth a combined $187M — down 31% from $273M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of SBBP and 24 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 19 added.

The largest buyer was Lyon Street Capital, adding an estimated $10.1M. The largest seller was BlackRock, cutting an estimated $9.32M.

  • 64 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q2 2018, down from 65 in Q1 2018.
  • Funds reported $187M of Strongbridge Biopharma plc. stock for Q2 2018, down 31% quarter-over-quarter.
  • 24 funds opened new Strongbridge Biopharma plc. positions in Q2 2018 and 25 closed out, a net change of -1 holder.
  • The largest Strongbridge Biopharma plc. buyer in Q2 2018 was Lyon Street Capital, an estimated $10.1M added.
  • The largest Strongbridge Biopharma plc. seller in Q2 2018 was BlackRock, an estimated $9.32M sold.

Based on aggregated 13F filings for Q2 2018.